Literature DB >> 32031601

A clinical perspective on the 2019 ESC/EAS guidelines for the management of dyslipidaemias: PCSK-9 inhibitors for all?

Iryna Dykun1, Amir A Mahabadi1, Tienush Rassaf1.   

Abstract

Entities:  

Year:  2020        PMID： 32031601     DOI： 10.1093/eurheartj/ehaa005

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  3 in total

1.  Suboptimal management of dyslipidemia in everyday clinical practice: Alarming signals from real-world data.

Authors:  Vasilios G Athyros; Konstantinos Stavropoulos; Konstantinos P Imprialos; Michael Doumas
Journal:  Int J Cardiol       Date:  2020-07-04       Impact factor: 4.164

2.  Peripheral artery disease in Germany (2009-2018): Prevalence, frequency of specialized ambulatory care and use of guideline-recommended therapy - A population-based study.

Authors:  Christos Rammos; Martin Steinmetz; Julia Lortz; Amir A Mahabadi; Olga Petrikhovich; Kristina Kirsch; Ramona Hering; Mandy Schulz; Tienush Rassaf
Journal:  Lancet Reg Health Eur       Date:  2021-05-03

3.  Treatment Patterns of Lipid-Lowering Therapy in Patients with Coronary Artery Disease Aged Above and Below 75 Years: A Retrospective Cross-Sectional Study of 1500 Patients in a Tertiary Care Referral Center in Germany.

Authors:  Iryna Dykun; Daniela Wiefhoff; Matthias Totzeck; Fadi Al-Rashid; R Alexander Jánosi; Stefanie Hendricks; Tienush Rassaf; Amir A Mahabadi
Journal:  Drugs Aging       Date:  2020-07       Impact factor: 3.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.